Status:
COMPLETED
Effectiveness of Intermittent Bladder Catheterization (IBC) in Reducing Recurrence of Urethral Stricture
Lead Sponsor:
University of Health Sciences Lahore
Conditions:
Urethral Stricture
Eligibility:
FEMALE
35-65 years
Phase:
NA
Brief Summary
The goal of this randomized controlled trial is to To assess the effectiveness of intermittent bladder catheterization (IBC) in reducing the recurrence of urethral stricture among females in tertiary ...
Detailed Description
Urethral stricture is a known pathology with significant health related issues ranging from mild lower urinary tract symptoms to severe urinary retention or even renal failure. Female urethral strictu...
Eligibility Criteria
Inclusion
- Female patients with diagnosis of urethral stricture.
- Age between 35 - 65 years.
- Females with Body mass index (BMI) \< 30.
- Female without any psychiatric illness whose Abbreviated Mental Test Score \[AMTS\] lies between 7-10.
- Females with moderate to severe urinary symptoms score which lies between 8-35, on American Urological Association (AUA) symptom score.
- Underwent urethral dilation at least once by urologist with subsequent advice of Intermittent Bladder Catheterization (IBC) by trained nurse.
- At presentation \>14Fr nelaton catheter could passed per urethra for Intermittent Bladder Catheterization (IBC).
- Female who can read Urdu or English will be included.
Exclusion
- Any patient with concomitant bladder or urethral pathology other than urethral stricture.
- Patients unable to perform Intermittent Bladder Catheterization (IBC) due to any physical disability.
Key Trial Info
Start Date :
June 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06064968
Start Date
June 20 2024
End Date
October 1 2024
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHS
Lahore, Punjab Province, Pakistan, 54000